Retropupillary iris-claw intraocular lens implantation in aphakic patients.


Journal

Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376

Informations de publication

Date de publication:
04 2020
Historique:
entrez: 17 3 2020
pubmed: 17 3 2020
medline: 15 5 2021
Statut: ppublish

Résumé

To evaluate the outcomes of implantation of an iris-claw intraocular lens (IC-IOL) in retropupillary position in aphakic patients. We conducted a prospective interventional study, including 36 aphakic eyes with inadequate capsular support. The postoperative examination included best-corrected visual acuity (BCVA), intraocular pressure (IOP) measurement, central corneal thickness (CCT), and anterior segment examination with emphasis on the anterior chamber reaction and shape of pupil. Follow-up was done for 3 months. Thirty-six eyes of 34 patients, including 22 right eyes and 14 left eyes were included. Indications for surgery were complicated cataract surgery in 38.9% (n = 14), aphakia in 27.8% (n = 10), pseudophakic bullous keratopathy in 16.7% (n = 6), dislocated posterior chamber IOL (PCIOL) in 11.1% (n = 4), IC drop in 2.8% (n = 1), and subluxated PCIOL in 2.8% (n = 1). Postoperatively, the visual acuity improved by at least two lines in 32 (88.9%) and worsened in four (11.1%) eyes at the end of three months. Mean postoperative IOP at the end of the third month was 12.42 mmHg (standard deviation [SD] 2.57; range 11.55-13.29 mmHg). The mean postoperative CCT at the end of the third month was 542.42 microns (SD 13.77; range 537.76-547.07 microns). Sixteen eyes (44.4%) had horizontally oval pupil, eleven eyes (30.6%) had round pupil, and nine eyes (25%) had irregular pupil. Twenty-three eyes (63.9%) presented with significant anterior chamber reaction and seven eyes (19.4%) had corneal stromal edema on postoperative day 1. Our study demonstrated that retropupillary IC-IOL implantation in eyes without adequate capsular support is an effective and safe procedure with a good visual outcome and fewer complications.

Identifiants

pubmed: 32174577
pii: IndianJOphthalmol_2020_68_4_597_280744
doi: 10.4103/ijo.IJO_1043_19
pmc: PMC7210845
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

597-602

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Déclaration de conflit d'intérêts

None

Références

J Refract Surg. 2013 Oct;29(10):685-91
pubmed: 23898947
Korean J Ophthalmol. 1991 Jun;5(1):42-6
pubmed: 1942602
Indian J Ophthalmol. 2016 Jan;64(1):45-9
pubmed: 26953023
Indian J Ophthalmol. 1986;34:181-2
pubmed: 3155064
Clin Exp Ophthalmol. 2012 Dec;40(9):849-54
pubmed: 22594520
Graefes Arch Clin Exp Ophthalmol. 2009 Apr;247(4):457-62
pubmed: 18787833
Arch Ophthalmol. 1994 Oct;112(10):1311-9
pubmed: 7945033
J Cataract Refract Surg. 2011 Sep;37(9):1667-72
pubmed: 21855764
Surv Ophthalmol. 2005 Sep-Oct;50(5):429-62
pubmed: 16139038
J Cataract Refract Surg. 1996 Mar;22(2):247-52
pubmed: 8656393
J Cataract Refract Surg. 2003 Feb;29(2):301-8
pubmed: 12648641
Acta Ophthalmol (Copenh). 1993 Aug;71(4):482-6
pubmed: 8249578
Indian J Ophthalmol. 2016 Dec;64(12):878-883
pubmed: 28112126
Int Med Case Rep J. 2016 Oct 31;9:337-340
pubmed: 27843355
J Cataract Refract Surg. 2005 Jul;31(7):1320-6
pubmed: 16105601
J Cataract Refract Surg. 1996 Dec;22(10):1476-84
pubmed: 9051506
J Cataract Refract Surg. 2007 Feb;33(2):254-7
pubmed: 17276266
Eye (Lond). 1991;5 ( Pt 6):694-8
pubmed: 1800168
Arch Ophthalmol. 1989 Jul;107(7):1078-83
pubmed: 2665697
J Cataract Refract Surg. 1996 Sep;22(7):951-4
pubmed: 9041088
Ophthalmic Surg. 1992 May;23(5):308-15
pubmed: 1603529
J Cataract Refract Surg. 2003 Sep;29(9):1663-7
pubmed: 14522283
J Cataract Refract Surg. 2008 Sep;34(9):1433-8
pubmed: 18721701
PLoS One. 2015 Jun 25;10(6):e0126614
pubmed: 26110864
Clin Ophthalmol. 2014;8:137-41
pubmed: 24391439
J Cataract Refract Surg. 2014 Sep;40(9):1488-97
pubmed: 25135541
J Cataract Refract Surg. 1994 Jan;20(1):34-9
pubmed: 8133477
Refract Corneal Surg. 1990 Sep-Oct;6(5):353-6
pubmed: 2257261
Br J Ophthalmol. 2014 May;98(5):658-63
pubmed: 24489374
J Fr Ophtalmol. 2000 Jan;23(1):73-80
pubmed: 10733359
J Cataract Refract Surg. 2013 Aug;39(8):1211-8
pubmed: 23726133
J Cataract Refract Surg. 1993 Jan;19(1):64-7
pubmed: 8426325
BMC Ophthalmol. 2015 Oct 27;15:143
pubmed: 26507387
Ophthalmology. 1993 Nov;100(11):1636-9
pubmed: 8233388
Arch Ophthalmol. 2004 Aug;122(8):1112-6
pubmed: 15302649
J Am Intraocul Implant Soc. 1980 Apr;6(2):166-7
pubmed: 6997251
Cornea. 2009 Aug;28(7):741-6
pubmed: 19574915
J Cataract Refract Surg. 1998 Aug;24(8):1039-49
pubmed: 9719962

Auteurs

C V Sumitha (CV)

Department of Ophthalmology, K.S Hegde Charitable Hospital, Deralakatte, Mangalore, Karnataka, India.

Vijay Pai (V)

Department of Ophthalmology, K.S Hegde Charitable Hospital, Deralakatte, Mangalore, Karnataka, India.

Mithun Thulasidas (M)

Centre for Sight Eye Institute, Plot No. 9, Sector 9, Dwarka, New Delhi, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH